Seaheck Wednesday, 11/08/17 10:03:46 AM
Just wanted
Seaheck Wednesday, 11/08/17 10:03:46 AM
Just wanted to post real quick. I know it's been a while, I'm just laying low while everything plays out over the next months.
So the FDA application was already completed when the pre clinical results were announced. A few things had to happen before they submitted the application. FDA approval into trials is anticipated to happen in 30-60 days (that's short and long expectation of a response).
Once we get notification from FDA, we are going to get a big "newsy" PR that will take the share price higher than anybody here has seen unless you've been in here for years. It should stay there also. Should be a great end of 2017, beginning pretty soon and that momentum should carry on through all of 2018, with expected FDA success plus the other pre clinicals finishing up and moving into FDA trials.
I'll post periodically if I have important news. Good things coming soon.
Endonovo Therapeutics, Inc. (ENDV) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Empowering SRPT Shareholders to Take Legal Action In the financial landscape, shareholders of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) have a significant opportunity to advocate for their rights through a class action lawsuit initiated by DJS Law Group. The firm is dedicated to representing investors who believe they have been misled regarding the safety and revenue...
Continue Reading
Understanding Foresight Group's Share Buyback Program The global investment landscape is constantly evolving, and Foresight Group Holdings Limited, renowned for their expertise in real assets and growth capital, has recently made headlines with its share buyback initiative. This strategic move not only reflects the company's confidence in its future but also highlights...
Continue Reading
ProSense® Cryoablation Technology: A Remarkable Advancement in Tumor Treatment IceCure Medical Ltd. is drawing significant attention with its ProSense® system, an innovative cryoablation technology that provides a more effective and less invasive option for treating tumors. This technique utilizes liquid nitrogen, which is proven to be both safer and more economical...
Continue Reading
Mangoceuticals Secures Capital Through Equity Offering Mangoceuticals, Inc. (NASDAQ:MGRX), a health services company, recently disclosed a strategic maneuver to enhance its capital. The company sold 33,333 shares of common stock to Platinum Point Capital, garnering net proceeds of $78,787. This is a notable step in their ongoing efforts to finance operations and implement...
Continue Reading
Marksman Titan Security Group Acquires Priebe Security Services Marksman Security Services, LLC, part of the Marksman Titan Security Group, has recently made headlines with its acquisition of Priebe Security Services, a notable security provider in Central Texas. This strategic move not only enhances the company's footprint in the region but also brings together two...
Continue Reading
